查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832091

2025 年至 2033 年血液采集市场规模、份额、趋势及预测（依产品、应用、最终用途及地区）

Blood Collection Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球血液采集市场规模达72.6亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到103.6亿美元，2025-2033年期间的复合年增长率为4.03%。目前，北美占据市场主导地位，2024年将占据41.2%的显着市场。由于大众医疗保健需求的不断增长、对经济实惠且精准的诊断测试的需求不断增长以及采集技术的不断进步，全球市场正在不断扩张。

市场成长主要受糖尿病、癌症和心血管疾病等慢性疾病盛行率上升的驱动，这些疾病需要频繁的血液检测和监测。医疗基础设施投资的增加（尤其是在新兴经济体）以及对先进诊断技术日益增长的需求也促进了市场的成长。捐血活动的增加以及针对血液短缺的宣传项目正在积极地影响需求。采血设备的技术进步，例如微创技术，提高了患者的舒适度和安全性，促进了采血设备的普及。此外，全球老年人口的增长以及外科手术和个人化医疗的增多，也增加了对采血服务的需求。监管支持以及对研究和医疗创新的资助正在进一步推动市场扩张。

美国是一个重要的区域市场，主要原因是人口中糖尿病、癌症和心血管疾病等慢性病的盛行率不断上升，需要频繁进行血液诊断和监测。根据美国国家慢性疾病预防与健康促进中心 2024 年的研究报告，约有 1.29 亿美国人患有一种或多种主要慢性病，其中 42% 患有两种或两种以上，12% 患有五种或五种以上。十大主要死亡原因中有五种与可预防和可治疗的慢性病密切相关。慢性病占美国每年 4.1 兆美元医疗保健费用的 90%，在过去二十年中，其盛行率一直在稳步上升。全国完善的医疗基础设施和先进的医疗技术正在推动高效采血系统的创新和采用。在政府倡议和非营利组织的支持下，人们对捐血重要性的认识不断提高，进一步推动了市场成长。外科手术的增多，特别是在老龄化人口中，加上对早期疾病检测和个人化医疗的日益重视，对整体市场需求做出了重大贡献。

血液采集市场趋势：

慢性病增长导致手术数量增加

全球采血市场正经历显着成长，这得益于医院剖腹产和复杂手术等外科手术数量的增加。根据美国国立卫生研究院 (NIH) 的数据，印度的剖腹产率从 2016 年的 17.2% 上升到 2021 年的 21.5%，凸显了对采血产品的需求不断增长。此外，久坐生活方式和慢性病引起的疾病也在增加，因此需要频繁进行健康检查和血液检测。例如，在英国，每年报告的癌症新病例超过 385,000 例，从而强调了采血在疾病诊断中的重要性。这种模式表明，随着非传染性疾病负担的加重，采血产品在治疗和诊断医疗保健中的重要性正在增加，这也推动了市场的发展。

政府倡议和宣传项目促进捐血

全球各地政府的积极措施在刺激血液采集市场成长方面发挥着至关重要的作用。各种宣传活动正在进行，以提高人们对捐血必要性的认识，这对市场产生了积极影响。这些活动提倡自愿捐血，并确保有足够的血液及相关成分来满足医疗需求。公共卫生措施正在提升常规捐血的救命能力，营造以社区为基础的护理文化。在这方面，透过进行以紧急情况下的血液采集、慢性病和灾害管理为重点的活动，这些项目能够填补供应链的缺口，尤其是在服务不足的地区。各国政府的此类措施为常规和关键应用提供了可持续的血液资源流，从而推动了全球血液市场的成长。

科技进步彻底改变了血液采集方式

技术创新正在透过提高效率和患者舒适度来改变采血市场。例如，用于糖尿病和糖尿病前期患者糖化血红蛋白 (HbA1c) 检测的按钮式采血系统。这些创新缩短了样本采集时间，减轻了患者不适感，并提高了诊断准确性。由于自动化技术的进步，一些采血系统可以与诊断平台集成，实现即时无缝资料传输。此外，这些技术满足了日益增长的预防保健和个人化医疗需求，因为快速且精准的诊断是此类实践的重要因素。此外，减少错误和提高工作流程效率的进步正在推动先进采血工具的普及。广泛的研发 (R&D) 活动正在推动市场对创新产品的需求，以满足现代医疗保健系统不断变化的需求。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球血液采集市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 针头和注射器
  • 采血管
    • 关键部分
      • 血清分离
      • 乙二胺四乙酸
      • 肝素
      • 血浆分离
  • 血袋
  • 其他的

第七章：市场区隔：依应用

  • 诊断
  • 治疗

第 8 章：市场区隔：最终用途别

  • 医院
  • 诊断中心
  • 血库
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • FL MEDICAL srl
    • Greiner AG
    • Haemonetics Corporation
    • McKesson Corporation
    • Medtronic plc
    • Nipro Corporation
    • Qiagen NV
    • Quest Diagnostics
    • Sarstedt AG & Co. KG
    • Terumo Corporation
Product Code: SR112025A4975

The global blood collection market size was valued at USD 7.26 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 10.36 Billion by 2033, exhibiting a CAGR of 4.03% during 2025-2033. North America currently dominates the market, holding a significant market share of 41.2% in 2024. The global market is expanding due to the increasing healthcare needs among the masses, the rising demand for affordable and precise diagnostic tests, and continual advancements in collection technologies.

The market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require frequent blood testing and monitoring. Increasing healthcare infrastructure investments, particularly in emerging economies, and growing demand for advanced diagnostic techniques also contribute to the market growth. The increasing blood donation campaigns and awareness programs against blood shortages are positively influencing the demand. Technological advancement in blood collection devices, such as minimally invasive techniques, enhances patient comfort and safety, which in turn promotes adoption. In addition, the growing geriatric population across the globe and the increasing surgical procedures and personalized medicine are enhancing the requirement for blood collection services. Regulatory support and funding for research and healthcare innovations are further driving market expansion.

The United States stands out as a key regional market, primarily driven by the rising prevalence of chronic diseases, including diabetes, cancer, and cardiovascular conditions among the population, necessitating frequent blood diagnostics and monitoring. According to a 2024 research report by the National Center for Chronic Disease Prevention and Health Promotion, about 129 million Americans have one or more major chronic conditions, of whom 42% have two or more, and 12% have five or more. Five of the top 10 leading causes of death are strongly related to preventable and treatable chronic conditions. Chronic diseases account for 90% of the annual USD 4.1 Trillion U.S. health care costs, and their prevalence has been increasing steadily for the past two decades. The well-established healthcare infrastructure across the country with advanced medical technologies are driving innovation and adoption of efficient blood collection systems. Increased awareness regarding the importance of blood donations, supported by government initiatives and nonprofit campaigns, is further fueling the market growth. Rising surgical procedures, especially in aging population, coupled with the growing emphasis on early disease detection and personalized medicine, are contributing significantly to overall market demand.

Blood Collection Market Trends:

Rising Number of Surgeries Amid Chronic Disease Growth

The global blood collection market is witnessing significant growth driven by the rising number of surgical procedures in hospitals, such as C-sections and complex surgeries. According to the National Institutes of Health (NIH), the rate of C-sections in India rose from 17.2% in 2016 to 21.5% in 2021, highlighting the growing demand for blood collection products. Besides, the diseases caused by sedentary lifestyles and chronic diseases are also increasing, thereby creating a requirement for frequent health checkups and blood tests. For example, in the UK, over 385,000 new cancer cases are reported every year, thereby emphasizing the significance of blood collection in disease diagnosis. This pattern indicates that the importance of blood collection products in both curative and diagnostic healthcare is increasing with the growing burden of non-communicable diseases, which is also propelling the market.

Government Initiatives and Awareness Programs Bolstering Blood Donation

Favorable government initiatives across the globe are playing a crucial role in stimulating the growth of the blood collection market. Various campaigns are being initiated to spread awareness about the need for blood donation, which is positively influencing the market. This initiative promotes voluntary donations and ensures adequate blood and related components for medical requirements. Public health initiatives are promoting the lifesaving capability of routine blood donation, creating a culture of community-based care. In this regard, through campaigns that focus on blood collection for emergencies, and management of chronic diseases, and disasters, the programs are able to fill gaps in supply chains, especially in the underserved areas. Such initiatives by governments are fueling the global growth of the market with sustainable flows of blood resources for routine as well as critical applications.

Technological Advancements Revolutionizing Blood Collection

Technological innovations are transforming the blood collection market by enhancing efficiency and patient comfort. For instance, the push-button blood collection system for HbA1c testing in diabetic and prediabetic patients. These innovations reduce sample collection time, decrease patient discomfort, and improve diagnostic accuracy. As a result of advancements in automation, several blood collection systems integrate with diagnostic platforms for a seamless transfer of data in real-time. In addition, these technologies address a growing need for preventive care and personalized medicine, as quick and precise diagnostics serve as an important factor for such practices. In addition, advancements that reduce errors and increase workflow efficiency are increasing the adoption of advanced blood collection tools. Extensive research and development (R&D) activities are impelling the market for innovative products that serve to meet the changing demands of modern healthcare systems.

Blood Collection Industry Segmentation:

Analysis by Product:

  • Needles and Syringes
  • Blood Collection Tubes
    • Serum-separating
    • EDTA
    • Heparin
    • Plasma-separating
  • Blood Bags
  • Others

Needles and syringes stand as the largest component in 2024, holding around 29.2% of the market. Needles and syringes are the leading products across the globe in terms of market share as they find extensive application in healthcare institutions. They are used to carry out blood sampling, transfusion, and diagnostic procedures. They play an important role in a multitude of medical procedures such as carrying out routine blood tests and emergency care and managing long-term diseases such as diabetes, and cancer. They are preferred by medical personnel due to their reliability and ease of use along with being cost-effective. Apart from these, improvements in the technology used in needles include ultra-slim needles and safety-engineered devices, that aid in lowering the risks for needlestick injuries. Increased rates of chronic conditions, an increasing rate of surgical intervention, and more thrust toward preventive care are creating demand for needles and syringes.

Analysis by Application:

  • Diagnostics
  • Treatment

Diagnostics leads the market with around 66.7% of market share in 2024. The largest product segment is diagnostics in the global blood collection market, led by a rise in chronic diseases and the resultant increase in the demand for early and accurate diagnosis of these diseases. In modern medicine, blood diagnostics help identify a variety of conditions including cancer, diabetes, cardiovascular and infectious diseases. The increasing trend of regular health check-ups, which are being increasingly conducted to check lifestyle-related conditions, is also increasing the demand for diagnostic tools. Technological developments, including automated analyzers and rapid diagnostic kits, are enhancing the speed and accuracy of blood tests and are strengthening their dominance in the market.

Analysis by End Use:

  • Hospitals
  • Diagnostics Centers
  • Blood Banks
  • Others

Hospitals lead the market with around 37.2% of market share in 2024. Hospitals constitute the largest percentage in the world market as it performs most of the diagnostic and therapeutic procedures in-house. A medical center primarily for surgery, trauma, chronic conditions, and emergency interventions requires blood collection products to diagnose conditions as promptly as possible and to treat the patients correctly. Increasing surgical procedures involving complicated organ transplantations and cancer surgery are expanding the requirement for blood collection solutions. Hospitals also act as important centers for blood banks and transfusion services; therefore, they play a key role in the supply chain of blood and blood components. Additionally, the rising prevalence of chronic diseases and lifestyle-related diseases also calls for regular testing of blood in hospital labs, thus consolidating its position in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 41.2%. North America accounts for the largest share of the market on account of its well-developed healthcare infrastructure, higher incidence of chronic diseases, and increasing penetration of advanced diagnostic technologies. High lifestyle-related disorders such as diabetes, cardiovascular diseases, and cancer further result in increased demand for blood collection products in the region. The increasing number of surgical procedures, coupled with the strong blood donation culture in the region, supports the demand for efficient blood collection solutions. Government campaigns encouraging blood donation and high regulatory standards ensure the quality and safety of blood collection processes, thereby contributing to market growth. Furthermore, technological advancement in North America leads it to the forefront of innovative practices.

Key Regional Takeaways:

United States Blood Collection Market Analysis

In 2024, United States accounted for 82.50% of the North America blood collection market. The blood collection market in the United States is expanding as healthcare providers are adopting advanced technologies to enhance their diagnostic capabilities. Hospitals, diagnostic centers, and clinics focus on improving the efficiency and accuracy of blood collection processes through the integration of automated blood collection systems, reduced human errors, and patient discomfort. The growing emphasis on preventive healthcare is prompting an increased demand for regular blood tests, which are being utilized to monitor chronic conditions and ensure early diagnosis. According to American Diabetes Association, 38.4 million people have diabetes in the United States which is 11.6% of the U.S. population. The continuous trend toward minimally invasive blood collection, such as capillary blood collection and fingerstick technologies, is mainly driven by the increasing demand for personalized health care. Increasingly, health care providers are also investing in point-of-care testing solutions that enable quicker and more accessible blood collection in remote and underserved areas. Health-conscious consumers and increasing awareness of bloodborne diseases also enhance the demand for blood donation and testing services. Rising cases of chronic diseases such as diabetes, cardiovascular disease, and cancer are continually driving the need for blood tests in monitoring and controlling the progression of these diseases. Along with these, other factors such as improvement in equipment and consumables for collecting blood continue to influence the growth of the U.S. blood collection market.

Asia Pacific Blood Collection Market Analysis

The blood collection market is growing in Asia Pacific due to investments in the healthcare infrastructure of emerging economies, such as India and China, which are developing medical facilities and diagnostic capabilities. Hospitals and diagnostic centers are also rapidly adopting automated blood collection devices, improving efficiency and reducing human error. The initiatives in the government area related to the betterment of the public health systems are also on an uptrend, which emphasizes that there should be a reasonable price and easy access to diagnostic services. With this growth in chronic diseases and with age, the elderly population, the demand for check-up on health and blood tests has increased. According to United Nations Population Fund (UNFPA), the elderly population is 153 million (aged 60 and above) in the year 2023 across India. Simultaneously, rising awareness about the importance of early disease detection is leading to greater patient participation in routine medical examinations. The growth of medical tourism, especially in countries like Thailand and Singapore, is also contributing to the expansion of the market, as international patients look for advanced diagnostic services. There is also a growing trend toward less invasive, safer, and more comfortable blood collection methods, which further drives the adoption of new technologies in the blood collection sector. These developments are collectively fueling the ongoing growth of the blood collection market in the Asia Pacific region.

Europe Blood Collection Market Analysis

The market for blood collection in Europe is showing growth, as healthcare service providers have become more focused on improving their capabilities to diagnose and ultimately improve patient outcomes. Improved technologies for blood collection, especially vacuum blood collection tubes, are being adopted by hospitals and diagnostic labs to make these processes much more streamlined and comfortable for patients. The demand for less invasive procedures is increasing, which directs the trend toward such products. An increased prevalence of chronic diseases like diabetes and cardiovascular diseases leads to increased blood test frequency, therefore propelling the market's growth. According to Eurostat, the number of in-patients with diseases of the circulatory system discharged from hospitals across the EU was 8.6 million in 2021. Additionally, healthcare regulations and the push for better patient safety are encouraging the use of safer, more reliable blood collection systems, reducing the risk of needle-stick injuries. Manufacturers are increasingly responding to a need for solutions that are bio-friendly, sustainable, biodegradable, or reusable blood collection products. Moreover, health and wellness among individuals in the region as well as the aging population are fuelling healthier preventive care outcomes, with an increase in demand for collecting blood services, governments are promoting public health infrastructures in the region. They further support research towards developing innovations in blood-collecting technologies, propelling growth within the regions.

Latin America Blood Collection Market Analysis

The blood collection market in Latin America is currently expanding due to several specific factors. Healthcare providers are increasingly adopting advanced diagnostic technologies, which are driving the demand for high-quality blood collection devices. Regulatory bodies in countries like Brazil and Mexico are strengthening health standards and guidelines, ensuring more stringent requirements for blood collection and testing procedures. In addition, the ongoing efforts to improve healthcare infrastructure across the region are promoting the expansion of blood banks and diagnostic centers, contributing to higher demand for collection supplies. Growing awareness about early disease detection and preventive healthcare is further fuelling the need for blood tests. Urbanization is also playing a crucial role, with more people gaining access to healthcare services in metropolitan areas, thus driving the usage of blood collection products. According to the Brazilian Institute of Geography and Statistics, in 2019, Brazil had 45,945 km 2 of urbanized areas, the equivalent to 0.54% of the Brazilian area. Moreover, the rise in non-communicable diseases, such as diabetes and cardiovascular conditions, is prompting an increased frequency of medical checkups and blood tests, significantly boosting demand. Additionally, governments and non-profit organizations are investing in programs that focus on improving blood donation drives and transfusion services, which are directly enhancing the demand for blood collection tools in the region. These factors are collectively fuelling the growth of the blood collection market in Latin America.

Middle East and Africa Blood Collection Market Analysis

The blood collection market in the Middle East and Africa (MEA) is witnessing robust growth as healthcare systems are increasingly prioritizing blood donation and collection services. Governments and healthcare authorities are enhancing their focus on improving healthcare infrastructure, which is driving the demand for modernized blood collection systems. Additionally, hospitals and diagnostic centers are adopting automated blood collection technologies to improve efficiency and reduce errors, contributing to market growth. With rising awareness about blood donation campaigns and the critical need for blood during emergencies, the market is expanding as donors are being increasingly encouraged through awareness programs. Healthcare facilities are actively investing in advanced blood collection devices such as blood collection tubes, needles, and vacutainers to ensure safe and sterile processes. The spike in chronic diseases such as anemia, cancer, and diabetes are also driving the demand for regular blood tests and blood transfusions. According to the International Diabetes Federation, in 2021, 990,900 adults were affected with diabetes across UAE. Furthermore, the ongoing global health challenges, including the COVID-19 pandemic, are compelling governments and NGOs to focus on establishing more organized blood donation systems to support treatment needs. These developments are accelerating innovation in blood collection techniques, thus making blood collection more efficient and accessible across the MEA region.

Competitive Landscape:

The market is highly competitive, with key players emphasizing innovations focused on improving the efficiency and safety of blood collection processes. They are investing in research and development (R&D) activities to create advanced devices such as automated blood collection systems, minimally invasive tools, and needle-free technologies. Strategic partnerships and acquisitions are being pursued to expand product portfolios and reach untapped markets. Several companies are also focusing on sustainability by developing eco-friendly and disposable products to reduce medical waste. In addition to this, digital solutions such as data integration to track and manage blood samples better are being implemented by the leading companies. Apart from this, the players are also expanding their production capacities while conducting awareness campaigns and training programs to improve the adoption of modern blood collection techniques to meet the growing demand.

The report provides a comprehensive analysis of the competitive landscape in the keyword market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • FL MEDICAL s.r.l
  • Greiner AG
  • Haemonetics Corporation
  • McKesson Corporation
  • Medtronic plc
  • Nipro Corporation
  • Qiagen N.V.
  • Quest Diagnostics
  • Sarstedt AG & Co. KG
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.What is blood collection?
  • 2.How big is the global blood collection market?
  • 3.What is the expected growth rate of the global blood collection market during 2025-2033?
  • 4.What are the key factors driving the global blood collection market?
  • 5.What is the leading segment of the global blood collection market based on product?
  • 6.What is the leading segment of the global blood collection market based on application?
  • 7.What is the leading segment of the global blood collection market based on end use?
  • 8.What are the key regions in the global blood collection market?
  • 9.Who are the key players/companies in the global blood collection market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Collection Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Needles and Syringes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Blood Collection Tubes
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Serum-separating
      • 6.2.2.2 EDTA
      • 6.2.2.3 Heparin
      • 6.2.2.4 Plasma-separating
    • 6.2.3 Market Forecast
  • 6.3 Blood Bags
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Banks
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 FL MEDICAL s.r.l.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Greiner AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Haemonetics Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 McKesson Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Nipro Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Qiagen N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Quest Diagnostics
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sarstedt AG & Co. KG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Collection Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Collection Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Collection Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Collection Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Blood Collection Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Blood Collection Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Blood Collection Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Collection (Needles and Syringes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Collection (Needles and Syringes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Collection (Blood Collection Tubes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Collection (Blood Collection Tubes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Collection (Blood Bags) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Collection (Blood Bags) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Collection (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Collection (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Collection (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Collection (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Collection (Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Collection (Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Collection (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Collection (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Collection (Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Collection (Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Collection (Blood Banks) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Collection (Blood Banks) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Collection (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Collection (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Blood Collection Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Blood Collection Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Blood Collection Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Blood Collection Industry: SWOT Analysis
  • Figure 78: Global: Blood Collection Industry: Value Chain Analysis
  • Figure 79: Global: Blood Collection Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Collection Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Collection Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Blood Collection Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Blood Collection Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Blood Collection Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Collection Market: Competitive Structure
  • Table 7: Global: Blood Collection Market: Key Players